PainReform Ltd. (PRFX)
NASDAQ: PRFX · Real-Time Price · USD
1.420
-0.030 (-2.07%)
At close: Aug 14, 2025, 4:00 PM
1.400
-0.020 (-1.41%)
After-hours: Aug 14, 2025, 4:40 PM EDT
PainReform Market Cap
PainReform has a market cap or net worth of $2.90 million as of August 14, 2025. Its market cap has increased by 111.66% in one year.
Market Cap
2.90M
Enterprise Value
-1.30M
1-Year Change
111.66%
Ranking
Category
Stock Price
$1.42
Market Cap Chart
Since the IPO on September 1, 2020, PainReform's market cap has decreased from $69.97M to $2.90M, a decrease of -95.86%. That is a compound annual growth rate of -47.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 2.92M | -0.55% |
| Dec 31, 2024 | 2.94M | -31.51% |
| Dec 29, 2023 | 4.29M | -2.35% |
| Dec 30, 2022 | 4.39M | -68.52% |
| Dec 31, 2021 | 13.94M | -65.00% |
| Dec 31, 2020 | 39.83M | -43.08% |
| Sep 1, 2020 | 69.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 572.45B |
| Johnson & Johnson | 415.03B |
| AbbVie | 349.87B |
| UnitedHealth Group | 235.35B |
| AstraZeneca | 229.47B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 227.16B |
| Novo Nordisk | 222.88B |